Physician profile
Samuel Carson
NPI 1366785172
$25,363.18
in general payments reported to CMS, 2019-2025
27 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $6,001 · 2021: $14K · 2022: $4,384 · 2023: $622 · 2024: $119 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,393.16 | 2020-2022 | |
| Tela Bio, INC. | $731.89 | 2020-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $361.12 | 2019-2023 | Phasix Mesh |
| Medtronic USA, INC. | $302.48 | 2020 | |
| Medtronic, INC. | $294.74 | 2021-2025 | Ligasure |
| Ethicon US, LLC | $242.55 | 2021-2025 | Vistaseal, Evarrest, Stratafix |
| Boston Scientific Corporation | $164.26 | 2021-2023 | Eluvia |
| Pacira Pharmaceuticals Incorporated | $118.99 | 2019-2021 | |
| Acera Surgical, INC. | $98.13 | 2020 | |
| Covidien Lp | $97.10 | 2019 | |
| Karl Storz Endoscopy-America | $94.95 | 2023 | Image1 S Connect |
| Braintree Laboratories, INC. | $56.95 | 2023-2025 | Suflave, Sutab |
| Apollo Endosurgery US INC | $48.86 | 2019 | |
| Allergan, INC. | $48.28 | 2019 | |
| Stryker Corporation | $47.53 | 2023 | Spy-Phi System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $45.31 | 2023-2025 | Kcentra |
| Abbvie INC. | $45.00 | 2025 | |
| Kerecis Limited | $35.61 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Enterra Medical, INC. | $19.60 | 2023 | |
| Smith+Nephew, INC. | $19.11 | 2022 | |
| Reprise Biomedical, INC. | $17.83 | 2025 | Miro3d |
| Solventum Corporation | $16.68 | 2024 | V.A.C.Instill, Promogran Prisma, Prevena Restor Arthroform |
| Merit Medical Systems INC | $15.79 | 2023 | Savi Scout |
| Olympus America INC. | $15.73 | 2023 | 4k Cable 8.5m |
| Pfizer INC. | $11.35 | 2019 | |
| Medical Device Business Services, INC. | $10.86 | 2019 | |
| Polynovo North America LLC | $9.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.